{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:45:03Z","timestamp":1777617903460,"version":"3.51.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jiac.2020.12.013","type":"journal-article","created":{"date-parts":[[2020,12,25]],"date-time":"2020-12-25T09:16:02Z","timestamp":1608887762000},"page":"755-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Successful treatment with famciclovir for varicella zoster virus infection resistant to acyclovir"],"prefix":"10.1016","volume":"27","author":[{"given":"Tomomi","family":"Oka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5534-6242","authenticated-orcid":false,"given":"Masakatsu","family":"Hishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouhei","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5218-4249","authenticated-orcid":false,"given":"Kimiyasu","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akifumi","family":"Takaori-Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.12.013_bib1","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(06)69561-5","article-title":"Varicella","volume":"368","author":"Heininger","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2020.12.013_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10096-016-2605-0","article-title":"Diagnosis, antiviral therapy, and prophylaxis of varicella-zoster virus infections","volume":"35","author":"Sauerbrei","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2020.12.013_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1368-7646(02)00021-3","article-title":"Resistance of herpesviruses to antiviral drugs: clinical impacts and molecular mechanisms","volume":"5","author":"Gilbert","year":"2002","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.jiac.2020.12.013_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-981-10-7230-7_6","article-title":"Antiviral drugs against alphaherpesvirus","volume":"1045","author":"Shiraki","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jiac.2020.12.013_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0166-3542(95)00941-8","article-title":"Famciclovir: review of clinical efficacy and safety","volume":"29","author":"Cirelli","year":"1996","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiac.2020.12.013_bib6","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1128\/JVI.06620-11","article-title":"In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs","volume":"86","author":"Andrei","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jiac.2020.12.013_bib7","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00277-015-2447-3","article-title":"Antiviral prophylaxis in patients with solid tumours and haematological malignancies--update of the guidelines of the infectious diseases working party (AGIHO) of the German society for hematology and medical oncology (DGHO)","volume":"94","author":"Sandherr","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.jiac.2020.12.013_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/sj.bmt.1703214","article-title":"Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"28","author":"Kanda","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2020.12.013_bib9","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21152","article-title":"Long-term ultralow-dose acyclovir against varicellazoster virus reactivation after allogeneic hematopoietic stem cell transplantation","volume":"83","author":"Asano-Mori","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jiac.2020.12.013_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0166-3542(92)90039-8","article-title":"Comparison of antiviral assay methods using cell-free and cell-associated varicella-zoster virus","volume":"18","author":"Shiraki","year":"1992","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiac.2020.12.013_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jdermsci.2016.02.006","article-title":"Subclinical generation of acyclovir-resistant herpes simplex virus with mutation of homopolymeric guanosine strings during acyclovir therapy","volume":"82","author":"Daikoku","year":"2016","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jiac.2020.12.013_bib12","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1128\/jvi.71.5.3872-3878.1997","article-title":"Homopolymer mutational hot spots mediate herpes simplex virus resistance to acyclovir","volume":"71","author":"Sasadeusz","year":"1997","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jiac.2020.12.013_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0166-3542(98)00057-6","article-title":"Emergence of resistance to acyclovir and penciclovir in varicella-zoster virus and genetic analysis of acyclovir-resistant variants","volume":"40","author":"Ida","year":"1999","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiac.2020.12.013_bib14","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/00002030-199006000-00014","article-title":"Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy","volume":"4","author":"Linnemann","year":"1990","journal-title":"AIDS"},{"key":"10.1016\/j.jiac.2020.12.013_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2169\/internalmedicine.56.6930","article-title":"The successful treatment of a cord blood transplant recipient with varicella zoster virus meningitis, radiculitis and myelitis with foscarnet","volume":"56","author":"Shimizu","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2020.12.013_bib16","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/rheumatology\/keq110","article-title":"Severe pneumonia by acyclovir-resistant varicella-zoster virus during etanercept therapy","volume":"49","author":"Manzano","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jiac.2020.12.013_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2011.08988.x","article-title":"Management of multidrug-resistant viruses in the immunocompromised host","volume":"156","author":"Sellar","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jiac.2020.12.013_bib18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1358\/dot.2017.53.11.2724803","article-title":"Helicase-primase inhibitor amenamevir for herpesvirus infection: towards practical application for treating herpes zoster","volume":"53","author":"Shiraki","year":"2017","journal-title":"Drugs Today"},{"key":"10.1016\/j.jiac.2020.12.013_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jmv.10562","article-title":"Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus","volume":"72","author":"Okuda","year":"2004","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.jiac.2020.12.013_bib20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0166-3542(95)00007-9","article-title":"Inhibitory action of acyclovir (ACV) and penciclovir (PCV) on plaque formation and partial cross-resistance of ACV-resistant varicella-zoster virus to PCV","volume":"27","author":"Hasegawa","year":"1995","journal-title":"Antivir Res"},{"key":"10.1016\/j.jiac.2020.12.013_bib21","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1128\/AAC.36.12.2747","article-title":"Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type1 (HSV-1), HSV-2, and varicella-zoster virus","volume":"36","author":"Earnshaw","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2020.12.013_bib22","first-page":"14","article-title":"The pharmacological profile of famciclovir","volume":"15","author":"Crumpacker","year":"1996","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.jiac.2020.12.013_bib23","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13061","article-title":"Effectiveness of acyclovir prophylaxis against varicella zoster virus disease after allogeneic hematopoietic cell transplantation: a systemic review and meta-analysis","volume":"21","author":"Wada-Shimosato","year":"2019","journal-title":"Transpl Infect Dis"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20304487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20304487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:01:39Z","timestamp":1761159699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20304487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1341321X20304487"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.12.013","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment with famciclovir for varicella zoster virus infection resistant to acyclovir","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}